Hantz Financial Services’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 2340 |
|
|
2025
Q1 | $0 | Hold |
250
| – | – | ﹤0.01% | 2037 |
|
|
2024
Q4 | $0 | Hold |
250
| – | – | ﹤0.01% | 1255 |
|
|
2024
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 1230 |
|
|
2024
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 1335 |
|
|
2024
Q1 | $0 | Hold |
250
| – | – | ﹤0.01% | 1336 |
|
|
2023
Q4 | $0 | Hold |
250
| – | – | ﹤0.01% | 1271 |
|
|
2023
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 1224 |
|
|
2023
Q1 | $0 | Hold |
250
| – | – | ﹤0.01% | 1245 |
|
|
2022
Q4 | $0 | Hold |
250
| – | – | ﹤0.01% | 1203 |
|
|
2022
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 1174 |
|
|
2022
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 1155 |
|
|
2022
Q1 | $0 | Buy |
+250
| New | – | ﹤0.01% | 1156 |
|